Back to search

Article

Towards More Powerful Antibodies for Fibroblast Growth Factor Receptors in Breast Cancer

2020-02-26

Abstract excerpt

Breast cancer (BC) is the most frequent form of malignancy and the second only to lung cancer as common cause of cancer-causing deaths in women. Notwithstanding many progresses in the field, metastatic BC has a very poor prognosis. As therapies are becoming more personalized to meet patients‘ needs, a better knowledge of the molecular biology leading to the disease unfolds the possibility to project more pre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3164c942-910d-543f-98fc-0c0d2aca2aee
DOI
10.20944/preprints202002.0382.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Towards More Powerful Antibodies for Fibroblast Growth Factor Receptors in Breast CancerDOI 10.20944/preprints202002.0382.v1
Current Status of Fibroblast Growth Factor Receptors Targeted Therapies in Breast CancerSemantic proximity
Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer.Semantic proximity
Fibroblast Growth Factor Receptors: From the Oncogenic Pathway to Targeted Therapy.Semantic proximity
FGFR4: A promising therapeutic target for breast cancer and other solid tumors.Semantic proximity
Epidermal growth factor receptor mutations in breast Cancer: Therapeutic challenges and way forward.Semantic proximity
Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An updateSemantic proximity
Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challengesSemantic proximity
FGFR a promising druggable target in cancer: Molecular biology and new drugs.Semantic proximity
Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel ApproachSemantic proximity
ErbB receptors: from oncogenes to targeted cancer therapiesSemantic proximity
Advances in EGFR/HER2-directed clinical research on breast cancer.Semantic proximity
Molecular Targeting the Human Epidermal Growth Factor Receptor-2 (HER2) Genes Across Various CancerSemantic proximity
Select a neighboring publication to make it the new centre.